Add preferred source The U.S. Treasury Department has added biotechnology as a new regulated sector under its proposed rules for the Comprehensive Outbound Investment National Security Act (COINS Act), moving to restrict equity investments and joint ventures in Chinese biotech companies. The scope covers pharmaceutical compounds, cell and gene therapies, gene sequencing, and lab automation.…
